Key result
Higher time-averaged MHR linked to ~27% greater incident MI risk per SD.
Why the study?
To explore whether an imbalance in circulating monocyte and HDL-C levels accounts for the residual risk of incident MI within optimal LDL-C levels.
Does an elevated time-averaged monocyte-to-HDL-C ratio increase the risk of incident myocardial infarction in individuals free of cardiovascular disease?
Does an elevated time-averaged monocyte-to-HDL-C ratio increase the risk of incident myocardial infarction in individuals free of cardiovascular disease?
Chronic imbalances in monocyte and HDL-C levels, reflected by an elevated monocyte-to-HDL-C ratio, are significantly associated with incident myocardial infarction, particularly among individuals with low LDL-C levels.
Elevated time-averaged MHR was associated with incident MI; leaves open its added value for risk stratification beyond LDL-C.
Background A sustained oversupply of monocytes and markedly decreased levels of high-density lipoprotein cholesterol (HDL-C) are notable in high-risk groups with residual cardiovascular risk, despite aggressive low-density lipoprotein cholesterol (LDL-C) lowering. This study aimed to explore whether an imbalance in circulating monocyte and HDL-C levels accounts for the residual risk of incident myocardial infarction (MI) within optimal LDL-C levels. Methods A total of 48,522 participants free of cardiovascular diseases from a real-life, prospective cohort (Kailuan study) were included. The monocyte count, HDL-C level and monocyte-to-HDL-C ratio (MHR), calculated as time-averaged cumulative and baseline values, were used as the exposures. Time-to-event survival analyses were conducted to examine the association between exposure and MI incidence, especially tests for risk heterogeneity across different LDL-C levels and other potential confounders. Results During a median follow-up of 10.06 years, 573 MI events occurred. An elevated time-averaged MHR was positively correlated with clustering of traditional risk factors but inversely correlated with LDL-C levels. After adjusting for potential confounders, each 1-SD increase in the time-averaged monocyte count, HDL-C level and MHR was significantly associated with a risk of 1.18 (95% CI: 1.08–1.28), 0.86 (95% CI: 0.79–0.93) and 1.27 (95% CI: 1.16–1.38), respectively. Individuals with LDL-C levels between 1.8 and 2.6 mmol/L had the lowest MI incidence but the highest MI risk (1.50, 95% CI: 1.27–1.79) with exposure to time-averaged MHR. In contrast, individuals with LDL-C levels ≥ 3.4 mmol/L had the highest MI incidence, but nonsignificant MI risk (HR: 0.99, 95% CI 0.82–1.19) was associated with time-averaged MHR. Conclusion Chronic imbalances in monocyte and HDL-C levels are significantly associated with incident MI among individuals with low LDL-C levels. Longitudinally tracing MHR changes and targeting elevated MHR may help to optimize risk assessment and management of MI.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question. Each 1-SD increase in the time-averaged monocyte-to-HDL-C ratio (MHR) was associated with a 27% increased risk of incident myocardial infarction (HR 1.27, 95% CI: 1.16–1.38).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: